Human Metabolome Technologies, Inc. (6090) Stock Statistics & Valuation Metrics

Human Metabolome Technologies, Inc. has a market cap or net worth of ¥3.63B. The enterprise value is ¥2.32B.

Human Metabolome Technologies, Inc. has 5,919,797 shares outstanding. The number of shares has decreased by -2.65% in one year.

Human Metabolome Technologies, Inc.’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 11.66%.

The current PE Ratio of Human Metabolome Technologies, Inc. is 28.5. Human Metabolome Technologies, Inc.’s PEG ratio is 2.95.

In the last 12 months, Human Metabolome Technologies, Inc. had revenue of 1.46B and earned 256.00M in profits. Earnings per share was 43.59.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Human Metabolome Technologies, Inc. pays an annual dividend of ¥18, resulting in a dividend yield of 2.35%

Human Metabolome Technologies, Inc. upcoming earnings date is Aug 7, 2026, TBA (Confirmed).

Human Metabolome Technologies, Inc. as a current ratio of 4.14, with Debt / Equity ratio of 5.58%

In the past 12 months, Human Metabolome Technologies, Inc. has paid 13.00M in taxes.

Human Metabolome Technologies, Inc. EV to EBITDA ratio is 8.54, with an EV/FCF ratio of 13.40.

Human Metabolome Technologies, Inc. has ¥1.59B in cash and marketable securities with ¥110.47M in debt, giving a net cash position of ¥1.48B billion.

Gross margin is 59.77%, with operating margin of 17.11%, and net profit margin of 17.59%.

The average price target for Human Metabolome Technologies, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―